ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag infectious disease disease medicine hiv

Blue T cell with other blurred T cells in the background
Woman Seemingly Cured of HIV After Umbilical Cord Transplant
Natalia Mesa, PhD | Feb 16, 2022 | 3 min read
Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.
Infectious Disease
The Scientist Staff | Nov 23, 1997 | 3 min read
Edited by: Steve Bunk J.L. Eron, S.L. Benoit, J. Jemsek, R.D. MacArthur, J. Santana, J.B. Quinn, D.R. Kuritzkes, M.A. Fallon, M. Rubin, "Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter," New England Journal of Medicine, 333:1662-9, 1995. (Cited in 120 publications through October 1997) Comments by Joseph Jemsek, Nalle Clinic, Charlotte, N.C. Among viruses that cause infectious disease, HIV is particularly adept at mutating
DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Stalking Infectious Disease
Eugene Russo | Jun 11, 2000 | 8 min read
Graphic: Cathleen Heard Law enforcement officials routinely use DNA fingerprinting as a tool to get the guilty punished. Defense lawyers often rely on the same tool to free the innocent. Though their labs may be less dramatic settings than criminal courtrooms, life science researchers also use DNA fingerprinting, but rather than capturing criminals, their goal is to keep tabs on a different sort of culprit: infectious disease. The technology has revolutionized the way diseases are tracked and th
Psychoactive Drugs and Infectious Diseases
A. J. S. Rayl | Apr 16, 2000 | 10+ min read
For nearly a century, it's been known that drugs of abuse alter the immune system. Since the outbreak of the AIDS epidemic in the early 1980s, however, an explosion of data has given rise to a rapidly evolving area of research. Investigators around the world have shown that such psychoactive drugs as heroin, morphine, cocaine, and marijuana affect both the neurophysiologic and immunologic systems. In recent years, researchers have produced strong experimental evidence that these drugs of a
Mapping Disease
Ed Yong | Apr 28, 2013 | 4 min read
Online tools could help to improve our patchy knowledge of the whereabouts of infectious diseases.
An Eclectic Look at Infectious Diseases
Ricki Lewis | Aug 20, 2000 | 7 min read
Graphic: Cathleen Heard A week after the controversial XIII International AIDS Conference in Durban, South Africa, a much smaller gathering in Atlanta took a broader view of the current emergence and reemergence of many infectious diseases. The International Conference on Emerging Infectious Diseases 2000, held July 16-19, attracted more than 2,000 attendees representing 35 nations. The Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State
Infectious Diseases Expert To Head National AIDS Unit
The Scientist Staff | Sep 17, 1989 | 5 min read
The National Institute of Allergy and Infectious Diseases has named George W. Counts as head of the newly established Clinical Research Management Branch in the Treatment Research Program of NIAID’s Division of AIDS. Prior to the appointment, Counts, 54, had been a professor of medicine at the University of Washington, Seattle, since 1975. He also served as director of the Clinical Microbiology Laboratory at the Fred Hutchinson Cancer Research Center in Seat- tle from 1985 to 1989. Co
Special Report
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Catherine Offord | Jun 16, 2020 | 10+ min read
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.
Humanized Mouse Models: Applications in Oncology and Infectious Disease
The Scientist Marketing Team | Aug 10, 2015 | 1 min read
In this webinar, our panel of experts will discuss the successes and caveats of using humanized mouse models to understand disease biology and evaluate therapeutic strategies. 

Run a Search

ADVERTISEMENT